| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 39,63% | 22,94% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 43,59% | 24,47% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 44,65% | 24,05% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 42,67% | 22,18% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) EUR | RVI BIOTECNOLOGÍA | 46,25% | 27,77% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 44,91% | 28,08% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 43,73% | 21,54% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 42,53% | 21,78% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | RVI BIOTECNOLOGÍA | 44,81% | 27,77% | · | · |
| FRANKLIN GLOBAL GREEN BOND S (ACC) EUR | RFI GLOBAL | 0,92% | 10,56% | · | · |
